AAAAAA

   
Results: 1-8 |
Results: 8
Synthesis and evaluation of efavirenz (Sustiva (TM)) analogues as HIV-1 reverse transcriptase inhibitors: Replacement of the cyclopropylacetylene side chain
Authors: Cocuzza, AJ Chidester, DR Cordova, BC Jeffrey, S Parsons, RL Bacheler, LT Erickson-Viitanen, S Trainor, GL Ko, SS
Citation: Aj. Cocuzza et al., Synthesis and evaluation of efavirenz (Sustiva (TM)) analogues as HIV-1 reverse transcriptase inhibitors: Replacement of the cyclopropylacetylene side chain, BIOORG MED, 11(9), 2001, pp. 1177-1179
Synthesis and evaluation of novel quinolinones as HIV-1 reverse transcriptase inhibitors
Authors: Patel, M McHugh, RJ Cordova, BC Klabe, RM Bacheler, LT Erickson-Viitanen, S Rodgers, JD
Citation: M. Patel et al., Synthesis and evaluation of novel quinolinones as HIV-1 reverse transcriptase inhibitors, BIOORG MED, 11(14), 2001, pp. 1943-1945
4,1-Benzoxazepinone analogues of efavirenz (Sustiva (TM)) as HIV-1 reversetranscriptase inhibitors
Authors: Cocuzza, AJ Chidester, DR Cordova, BC Klabe, RM Jeffrey, S Diamond, S Weigelt, CA Ko, SS Bacheler, LT Erickson-Viitanen, SK Rodgers, JD
Citation: Aj. Cocuzza et al., 4,1-Benzoxazepinone analogues of efavirenz (Sustiva (TM)) as HIV-1 reversetranscriptase inhibitors, BIOORG MED, 11(11), 2001, pp. 1389-1392
Human immunodeficiency virus type 1 mutations selected in patients failingefavirenz combination therapy
Authors: Bacheler, LT Anton, ED Kudish, P Baker, D Bunville, J Krakowski, K Bolling, L Aujay, M Wang, XV Ellis, D Becker, MF Lasut, AL George, HJ Spalding, DR Hollis, G Abremski, K
Citation: Lt. Bacheler et al., Human immunodeficiency virus type 1 mutations selected in patients failingefavirenz combination therapy, ANTIM AG CH, 44(9), 2000, pp. 2475-2484
Inhibition of clinically relevant mutant variants of HIV-1 by quinazolinone non-nucleoside reverse transcriptase inhibitors
Authors: Corbett, JW Ko, SS Rodgers, JD Gearhart, LA Magnus, NA Bacheler, LT Diamond, S Jeffrey, S Klabe, RM Cordova, BC Garber, S Logue, K Trainor, GL Anderson, PS Erickson-Viitanen, SK
Citation: Jw. Corbett et al., Inhibition of clinically relevant mutant variants of HIV-1 by quinazolinone non-nucleoside reverse transcriptase inhibitors, J MED CHEM, 43(10), 2000, pp. 2019-2030
Resistance to non-nucleoside inhibitors of HIV-I reverse transcriptase
Authors: Bacheler, LT
Citation: Lt. Bacheler, Resistance to non-nucleoside inhibitors of HIV-I reverse transcriptase, DRUG RESIST, 2(1), 1999, pp. 56-67
Unsymmetrical cyclic ureas as HIV-1 protease inhibitors: Novel biaryl indazoles as P2/P2' substituents
Authors: Patel, M Rodgers, JD McHugh, RJ Johnson, BL Cordova, BC Klabe, RM Bacheler, LT Erickson-Viitanen, S Ko, SS
Citation: M. Patel et al., Unsymmetrical cyclic ureas as HIV-1 protease inhibitors: Novel biaryl indazoles as P2/P2' substituents, BIOORG MED, 9(22), 1999, pp. 3217-3220
Expanded-spectrum nonnucleoside reverse transcriptase inhibitors inhibit clinically relevant mutant variants of human immunodeficiency virus type 1
Authors: Corbett, JW Ko, SS Rodgers, JD Jeffrey, S Bacheler, LT Klabe, RM Diamond, S Lai, CM Rabel, SR Saye, JA Adams, SP Trainor, GL Anderson, PS Erickson-Viitanen, SK
Citation: Jw. Corbett et al., Expanded-spectrum nonnucleoside reverse transcriptase inhibitors inhibit clinically relevant mutant variants of human immunodeficiency virus type 1, ANTIM AG CH, 43(12), 1999, pp. 2893-2897
Risultati: 1-8 |